RCT: New shorter regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease 8 Apr, 2021 | 08:47h | UTC New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial – The Lancet Infectious Diseases Commentary: Chagas disease: Shorter treatment just as effective as longer one, according to study in Bolivia published by The Lancet – Drugs for Neglected Diseases Initiative